C Huber1, M Rosilio, A Munnich, V Cormier-Daire. 1. Department of Medical Genetics and INSERM U781, Hôpital Necker Enfants Malades, 149 rue de Sèvres 75015 Paris, France.
Abstract
OBJECTIVE: To study the SHOX gene and the PAR1 region in individuals with short stature. METHODS: The study involved 56 cases of dyschondrosteosis and 84 cases of idiopathic short stature (ISS). The study was designed to determine the following: the prevalence of SHOX anomalies in ISS; the frequency of Madelung deformity in individuals with SHOX anomalies; and the value of a family history of short stature in deciding whether to test for the SHOX gene. RESULTS: 54 SHOX anomalies were observed, including 42 (68%) in the dyschondrosteosis group and 12 (15%) in the ISS group. The high frequency of SHOX anomalies in the ISS group can be explained by the large proportion of boys in this group, reflecting the difficulty in diagnosing dyschondrosteosis in young boys. Clinical evidence of Madelung deformity in six parents of ISS individuals emphasised the importance of family evaluation. Among the 54 SHOX anomalies, 33 PAR1 deletions were identified encompassing the SHOX gene (62%), one partial intragenic deletion (2%), nine deletions located downstream of the SHOX gene (16%), and 11 point mutations (20%). CONCLUSIONS: These data emphasise the value of using microsatellite markers located within and downstream of the SHOX gene.
OBJECTIVE: To study the SHOX gene and the PAR1 region in individuals with short stature. METHODS: The study involved 56 cases of dyschondrosteosis and 84 cases of idiopathic short stature (ISS). The study was designed to determine the following: the prevalence of SHOX anomalies in ISS; the frequency of Madelung deformity in individuals with SHOX anomalies; and the value of a family history of short stature in deciding whether to test for the SHOX gene. RESULTS: 54 SHOX anomalies were observed, including 42 (68%) in the dyschondrosteosis group and 12 (15%) in the ISS group. The high frequency of SHOX anomalies in the ISS group can be explained by the large proportion of boys in this group, reflecting the difficulty in diagnosing dyschondrosteosis in young boys. Clinical evidence of Madelung deformity in six parents of ISS individuals emphasised the importance of family evaluation. Among the 54 SHOX anomalies, 33 PAR1 deletions were identified encompassing the SHOX gene (62%), one partial intragenic deletion (2%), nine deletions located downstream of the SHOX gene (16%), and 11 point mutations (20%). CONCLUSIONS: These data emphasise the value of using microsatellite markers located within and downstream of the SHOX gene.
Authors: C Huber; V Cusin; M Le Merrer; M Mathieu; V Sulmont; N Dagoneau; A Munnich; V Cormier-Daire Journal: J Med Genet Date: 2001-05 Impact factor: 6.318
Authors: C Falcinelli; L Iughetti; A Percesepe; G Calabrese; F Chiarelli; M Cisternino; L De Sanctis; I Pucarelli; G Radetti; M Wasniewska; G Weber; L Stuppia; S Bernasconi; A Forabosco Journal: J Med Genet Date: 2002-06 Impact factor: 6.318
Authors: S F Flanagan; C F J Munns; M Hayes; B Williams; M Berry; D Vickers; E Rao; G A Rappold; J A Batch; V J Hyland; I A Glass Journal: J Med Genet Date: 2002-10 Impact factor: 6.318
Authors: Sara Benito-Sanz; N Simon Thomas; Céline Huber; Celine Huber; Darya Gorbenko del Blanco; Darya Gorbenko Del Blanco; Miriam Aza-Carmona; John A Crolla; Vivienne Maloney; Gudrun Rappold; Jesús Argente; Jesus Argente; Angel Campos-Barros; Valérie Cormier-Daire; Valerie Cormier-Daire; Karen E Heath Journal: Am J Hum Genet Date: 2005-08-15 Impact factor: 11.025
Authors: E Rao; B Weiss; M Fukami; A Rump; B Niesler; A Mertz; K Muroya; G Binder; S Kirsch; M Winkelmann; G Nordsiek; U Heinrich; M H Breuning; M B Ranke; A Rosenthal; T Ogata; G A Rappold Journal: Nat Genet Date: 1997-05 Impact factor: 38.330
Authors: S Schiller; S Spranger; B Schechinger; M Fukami; S Merker; S L Drop; J Tröger; H Knoblauch; J Kunze; J Seidel; G A Rappold Journal: Eur J Hum Genet Date: 2000-01 Impact factor: 4.246
Authors: Gerhard Binder; Alexandra Renz; Alicia Martinez; Ana Keselman; Volker Hesse; Stefan W Riedl; Gabriele Häusler; Susanne Fricke-Otto; Herwig Frisch; Juan Jorge Heinrich; Michael B Ranke Journal: J Clin Endocrinol Metab Date: 2004-09 Impact factor: 5.958
Authors: Anne Marie Ottesen; Lise Aksglaede; Inger Garn; Nicole Tartaglia; Flora Tassone; Claus H Gravholt; Anders Bojesen; Kaspar Sørensen; Niels Jørgensen; Ewa Rajpert-De Meyts; Tommy Gerdes; Anne-Marie Lind; Susanne Kjaergaard; Anders Juul Journal: Am J Med Genet A Date: 2010-05 Impact factor: 2.802
Authors: Sara Benito-Sanz; Alberta Belinchon-Martínez; Miriam Aza-Carmona; Carolina de la Torre; Celine Huber; Isabel González-Casado; Judith L Ross; N Simon Thomas; Andrew R Zinn; Valerie Cormier-Daire; Karen E Heath Journal: J Hum Genet Date: 2016-09-08 Impact factor: 3.172
Authors: Renata C Scalco; Suzana S J Melo; Patricia N Pugliese-Pires; Mariana F A Funari; Mirian Y Nishi; Ivo J P Arnhold; Berenice B Mendonca; Alexander A L Jorge Journal: J Clin Endocrinol Metab Date: 2009-11-19 Impact factor: 5.958
Authors: J Chen; G Wildhardt; Z Zhong; R Röth; B Weiss; D Steinberger; J Decker; W F Blum; G Rappold Journal: J Med Genet Date: 2009-07-02 Impact factor: 6.318